Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QoLATI
NCT04124198Active, not recruiting
- Start
- Mar 2019
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Randomised, open-label trial in oropharyngeal squamous cell carcinoma (OPSCC) (2 arms). Primary endpoint: MD Anderson Dysphagia Inventory at 12 months. Started Mar 2019; status: active, not recruiting.
02
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)
Beyond the preview
Go deeper on NCT04124198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04124198.